Similar Search Results

Creating R&D Incentives for Medicines for Neglected Diseases : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research

Müller-Langer, Frank - 2009

This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...

Persistent link: https://www.econbiz.de/10013521260

Leading pharmaceutical innovation : how to win the life science race

Gassmann, Oliver; Schuhmacher, Alexander; Zedtwitz, … - 2018 - Third edition

of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for … cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R … expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture …

Persistent link: https://www.econbiz.de/10012397599

Pharma-Einkauf : Qualitätsorientierte Prozesse – Rechtliche Rahmenbedingungen – Trends

Bergmann, Andreas - 2018

an den Einkauf von Fertigarzneimitteln -- Verpackungsmitteleinkauf in der Pharmaindustrie -- Einkauf von CRO …. Zahlreiche Praxisbeispiele zeigen Besonderheiten: die komplexe Struktur des Arzneimittel- und Gesundheitsmarktes entlang der … Auswirkungen auf den Einkauf in der Pharmaindustrie, z. B. Digitalisierung, Telemedizin, personalisierte Medizin, integrierte …

Persistent link: https://www.econbiz.de/10014019602

The Chemical and Pharmaceutical Industry in China : Opportunities and Threats for Foreign Companies

Festel, Gunter; Oels, Udo; Kreimeyer, Andreas; Zedtwitz, Max - 2005

Persistent link: https://www.econbiz.de/10013520463

Risk-sharing in the Pharmaceutical Industry : The Case of Out-licensing

Reepmeyer, Gerrit (contributor) - 2006

Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...

Persistent link: https://www.econbiz.de/10013520588

Leading Pharmaceutical Innovation : Trends and Drivers for Growth in the Pharmaceutical Industry

Gassmann, Oliver (contributor); … - 2008 - Second Edition

Persistent link: https://www.econbiz.de/10013520901

AIDS and Aid : A Public Good Approach

Sonntag, Diana - 2010

The Challenge: A Transnational Response to HIV/AIDS -- Profiling the Provision Status of Health-Promoting Public Goods Against AIDS -- International Transfers -- Regional Constraints and HIV/AIDS -- Summary and Concluding Remarks